{
    "medicine_id": "c737e2fdae3531d2b3ec244fff10c1a107aa7daa",
    "platform_id": "DB00081",
    "metadata": {
        "name": "Bexxar 0 61 mCi 1mL Injection",
        "composition": "0 61 mCi 1mL Tositumomab",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of non Hodgkin s lymphoma CD20 positive follicular",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Tositumomab binds to the CD20 antigen which is predominantly expressed on mature B cells and on 90 of B cell non Hodgkin s lympohomas The antibody leads to selective killing of B cells",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The risk or severity of adverse effects can be increased when Etanercept is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The risk or severity of adverse effects can be increased when Anakinra is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Infliximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Alefacept"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Efalizumab"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Antithymocyte immunoglobulin rabbit"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Daclizumab"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bevacizumab"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bleomycin"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trifluridine"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Propylthiouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Linezolid"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fludrocortisone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Azathioprine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mycophenolic acid"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trilostane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Estramustine"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Eculizumab"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Stepronin"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Castanospermine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with 2 Methoxyethanol"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Brequinar"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pirfenidone"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Briakinumab"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Abetimus"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Belatacept"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Desoximetasone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluorometholone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of neutropenia can be increased when Tositumomab is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Tositumomab is combined with Peginesatide"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00890",
                        "description": "Dienestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12487",
                        "description": "Promestriene may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may increase the thrombogenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Tositumomab may increase the immunosuppressive activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Tositumomab may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Drotrecogin alfa is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Streptokinase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dicoumarol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Argatroban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ardeparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenindione is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fondaparinux is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Warfarin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pentosan polysulfate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenprocoumon is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Heparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Enoxaparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Acenocoumarol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when 4 hydroxycoumarin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Coumarin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Desmoteplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ancrod is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fibrinolysin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rivaroxaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulodexide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Semuloparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Idraparinux is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Astaxanthin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Apixaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Otamixaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amediplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dabigatran etexilate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Danaparoid is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dalteparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tinzaparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ferulic acid is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when R warfarin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ethyl biscoumacetate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nadroparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ditazole is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Edoxaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Potassium citrate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sodium citrate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dextran is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bemiparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Parnaparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Desirudin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zinc citrate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antithrombin Alfa is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Protein C is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antithrombin III human is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Letaxaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Darexaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nafamostat is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Monteplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Gabexate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fluindione is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Protein S human is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Brinase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clorindione is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diphenadione is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tioclomarol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Melagatran is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Saruplase is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when S Warfarin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tocopherylquinone is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Edetate calcium disodium anhydrous is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dabigatran is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Troxerutin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Edetic acid is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Reviparin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of adverse effects can be increased when Eptifibatide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of adverse effects can be increased when Ticlopidine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of adverse effects can be increased when Clopidogrel is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of adverse effects can be increased when Tirofiban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of adverse effects can be increased when Dipyridamole is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Iloprost is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of adverse effects can be increased when Cilostazol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of adverse effects can be increased when Ridogrel is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of adverse effects can be increased when Resveratrol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of adverse effects can be increased when Nimesulide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of adverse effects can be increased when Tesmilifene is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of adverse effects can be increased when Defibrotide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of adverse effects can be increased when Beraprost is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of adverse effects can be increased when Ibudilast is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of adverse effects can be increased when Andrographolide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Caplacizumab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of adverse effects can be increased when Prasugrel is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of adverse effects can be increased when Cangrelor is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of adverse effects can be increased when Tranilast is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of adverse effects can be increased when Triflusal is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of adverse effects can be increased when Ticagrelor is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of adverse effects can be increased when Vorapaxar is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of adverse effects can be increased when Trapidil is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of adverse effects can be increased when Naftopidil is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of adverse effects can be increased when Ifetroban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Ketanserin is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of adverse effects can be increased when Indobufen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of adverse effects can be increased when Butylphthalide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of adverse effects can be increased when Ramatroban is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of adverse effects can be increased when Picotamide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of adverse effects can be increased when Cloricromen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of adverse effects can be increased when Linsidomine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of adverse effects can be increased when Buflomedil is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of adverse effects can be increased when Relcovaptan is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "Ocrelizumab may increase the immunosuppressive activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "Tositumomab may increase the myelosuppressive activities of Lipegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of adverse effects can be increased when Cetuximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00028",
                        "description": "The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00043",
                        "description": "The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00057",
                        "description": "The risk or severity of adverse effects can be increased when Indium In 111 satumomab pendetide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00076",
                        "description": "The risk or severity of adverse effects can be increased when Digoxin Immune Fab Ovine is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Capromab pendetide"
                    },
                    {
                        "drugbank-id": "DB00110",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Palivizumab"
                    },
                    {
                        "drugbank-id": "DB00113",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Technetium Tc 99m arcitumomab"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Panitumumab"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ranibizumab"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Galiximab"
                    },
                    {
                        "drugbank-id": "DB04949",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pexelizumab"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Epratuzumab"
                    },
                    {
                        "drugbank-id": "DB04962",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bectumomab"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Oregovomab"
                    },
                    {
                        "drugbank-id": "DB04988",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with IGN311"
                    },
                    {
                        "drugbank-id": "DB05006",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Adecatumumab"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Labetuzumab"
                    },
                    {
                        "drugbank-id": "DB05101",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Matuzumab"
                    },
                    {
                        "drugbank-id": "DB05111",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fontolizumab"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bavituximab"
                    },
                    {
                        "drugbank-id": "DB05139",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with CR002"
                    },
                    {
                        "drugbank-id": "DB05209",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rozrolimupab"
                    },
                    {
                        "drugbank-id": "DB05304",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Girentuximab"
                    },
                    {
                        "drugbank-id": "DB05336",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Obiltoxaximab"
                    },
                    {
                        "drugbank-id": "DB05405",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with XTL 001"
                    },
                    {
                        "drugbank-id": "DB05437",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with NAV 1800"
                    },
                    {
                        "drugbank-id": "DB05496",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Otelixizumab"
                    },
                    {
                        "drugbank-id": "DB05545",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with AMG 108"
                    },
                    {
                        "drugbank-id": "DB05550",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Iratumumab"
                    },
                    {
                        "drugbank-id": "DB05555",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Enokizumab"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ramucirumab"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Farletuzumab"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Veltuzumab"
                    },
                    {
                        "drugbank-id": "DB05793",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with PRO 542"
                    },
                    {
                        "drugbank-id": "DB05797",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with TNX 901"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB05892",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with RI 624"
                    },
                    {
                        "drugbank-id": "DB05915",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with MYO 029"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with CT 011"
                    },
                    {
                        "drugbank-id": "DB05941",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Leronlimab"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Glembatumumab vedotin"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Olaratumab"
                    },
                    {
                        "drugbank-id": "DB06049",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with IPH 2101"
                    },
                    {
                        "drugbank-id": "DB06050",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with TB 402"
                    },
                    {
                        "drugbank-id": "DB06101",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with IMC 1C11"
                    },
                    {
                        "drugbank-id": "DB06116",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Eldelumab"
                    },
                    {
                        "drugbank-id": "DB06162",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lumiliximab"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nimotuzumab"
                    },
                    {
                        "drugbank-id": "DB06241",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Clenoliximab"
                    },
                    {
                        "drugbank-id": "DB06304",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with BIIB015"
                    },
                    {
                        "drugbank-id": "DB06305",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sonepcizumab"
                    },
                    {
                        "drugbank-id": "DB06310",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Motavizumab"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Elotuzumab"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06322",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carotuximab"
                    },
                    {
                        "drugbank-id": "DB06324",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with XmAb 2513"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Teprotumumab"
                    },
                    {
                        "drugbank-id": "DB06360",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lucatumumab"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pertuzumab"
                    },
                    {
                        "drugbank-id": "DB06371",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Siplizumab"
                    },
                    {
                        "drugbank-id": "DB06467",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Apolizumab"
                    },
                    {
                        "drugbank-id": "DB06474",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sibrotuzumab"
                    },
                    {
                        "drugbank-id": "DB06550",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bivatuzumab"
                    },
                    {
                        "drugbank-id": "DB06557",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lerdelimumab"
                    },
                    {
                        "drugbank-id": "DB06599",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lexatumumab"
                    },
                    {
                        "drugbank-id": "DB06602",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Reslizumab"
                    },
                    {
                        "drugbank-id": "DB06606",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Teplizumab"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Catumaxomab"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Volociximab"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ofatumumab"
                    },
                    {
                        "drugbank-id": "DB08902",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Raxibacumab"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09105",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Asfotase alfa"
                    },
                    {
                        "drugbank-id": "DB09302",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Alirocumab"
                    },
                    {
                        "drugbank-id": "DB09303",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Evolocumab"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11604",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tetanus Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Eftrenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB11621",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Human Varicella Zoster Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11657",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tabalumab"
                    },
                    {
                        "drugbank-id": "DB11680",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ficlatuzumab"
                    },
                    {
                        "drugbank-id": "DB11685",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Figitumumab"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11715",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bapineuzumab"
                    },
                    {
                        "drugbank-id": "DB11731",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Depatuxizumab mafodotin"
                    },
                    {
                        "drugbank-id": "DB11746",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Onartuzumab"
                    },
                    {
                        "drugbank-id": "DB11756",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Solanezumab"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11826",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lampalizumab"
                    },
                    {
                        "drugbank-id": "DB11840",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dalotuzumab"
                    },
                    {
                        "drugbank-id": "DB11849",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Emibetuzumab"
                    },
                    {
                        "drugbank-id": "DB11850",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ublituximab"
                    },
                    {
                        "drugbank-id": "DB11856",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ligelizumab"
                    },
                    {
                        "drugbank-id": "DB11857",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Seribantumab"
                    },
                    {
                        "drugbank-id": "DB11862",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Landogrozumab"
                    },
                    {
                        "drugbank-id": "DB11866",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Romosozumab"
                    },
                    {
                        "drugbank-id": "DB11884",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vadastuximab Talirine"
                    },
                    {
                        "drugbank-id": "DB11914",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lebrikizumab"
                    },
                    {
                        "drugbank-id": "DB11930",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Varlilumab"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11959",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Crenezumab"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11976",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Anifrolumab"
                    },
                    {
                        "drugbank-id": "DB12023",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Benralizumab"
                    },
                    {
                        "drugbank-id": "DB12034",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gantenerumab"
                    },
                    {
                        "drugbank-id": "DB12053",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Visilizumab"
                    },
                    {
                        "drugbank-id": "DB12077",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Urelumab"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12090",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Patritumab"
                    },
                    {
                        "drugbank-id": "DB12102",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fulranumab"
                    },
                    {
                        "drugbank-id": "DB12104",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tarextumab"
                    },
                    {
                        "drugbank-id": "DB12118",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sotatercept"
                    },
                    {
                        "drugbank-id": "DB12119",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gevokizumab"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12152",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Simtuzumab"
                    },
                    {
                        "drugbank-id": "DB12157",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fasinumab"
                    },
                    {
                        "drugbank-id": "DB12159",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dupilumab"
                    },
                    {
                        "drugbank-id": "DB12169",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tralokinumab"
                    },
                    {
                        "drugbank-id": "DB12189",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Etrolizumab"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12205",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ganitumab"
                    },
                    {
                        "drugbank-id": "DB12213",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Etaracizumab"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12246",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Inclacumab"
                    },
                    {
                        "drugbank-id": "DB12250",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cixutumumab"
                    },
                    {
                        "drugbank-id": "DB12261",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ascrinvacumab"
                    },
                    {
                        "drugbank-id": "DB12274",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Aducanumab"
                    },
                    {
                        "drugbank-id": "DB12281",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Luspatercept"
                    },
                    {
                        "drugbank-id": "DB12296",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with GS 5745"
                    },
                    {
                        "drugbank-id": "DB12317",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vanucizumab"
                    },
                    {
                        "drugbank-id": "DB12331",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Labetuzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12335",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tanezumab"
                    },
                    {
                        "drugbank-id": "DB12342",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ensituximab"
                    },
                    {
                        "drugbank-id": "DB12344",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fezakinumab"
                    },
                    {
                        "drugbank-id": "DB12363",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dusigitumab"
                    },
                    {
                        "drugbank-id": "DB12396",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fresolimumab"
                    },
                    {
                        "drugbank-id": "DB12413",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Indusatumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12456",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bococizumab"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12520",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Plozalizumab"
                    },
                    {
                        "drugbank-id": "DB12534",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mavrilimumab"
                    },
                    {
                        "drugbank-id": "DB12560",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Blosozumab"
                    },
                    {
                        "drugbank-id": "DB12584",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bimagrumab"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12609",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tovetumab"
                    },
                    {
                        "drugbank-id": "DB12683",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lumretuzumab"
                    },
                    {
                        "drugbank-id": "DB12698",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ibalizumab"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12718",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Carlumab"
                    },
                    {
                        "drugbank-id": "DB12734",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Demcizumab"
                    },
                    {
                        "drugbank-id": "DB12773",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sifalimumab"
                    },
                    {
                        "drugbank-id": "DB12775",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Abituzumab"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12807",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Naptumomab Estafenatox"
                    },
                    {
                        "drugbank-id": "DB12815",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Crotedumab"
                    },
                    {
                        "drugbank-id": "DB12820",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Concizumab"
                    },
                    {
                        "drugbank-id": "DB12826",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Depatuxizumab"
                    },
                    {
                        "drugbank-id": "DB12844",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rontalizumab"
                    },
                    {
                        "drugbank-id": "DB12845",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Amatuximab"
                    },
                    {
                        "drugbank-id": "DB12849",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Clazakizumab"
                    },
                    {
                        "drugbank-id": "DB12891",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ozanezumab"
                    },
                    {
                        "drugbank-id": "DB12893",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sacituzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12917",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bimekizumab"
                    },
                    {
                        "drugbank-id": "DB12943",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Milatuzumab"
                    },
                    {
                        "drugbank-id": "DB12976",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Robatumumab"
                    },
                    {
                        "drugbank-id": "DB13017",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Rovalpituzumab Tesirine"
                    },
                    {
                        "drugbank-id": "DB13037",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Namilumab"
                    },
                    {
                        "drugbank-id": "DB13045",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Racotumomab"
                    },
                    {
                        "drugbank-id": "DB13073",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tregalizumab"
                    },
                    {
                        "drugbank-id": "DB13127",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Olokizumab"
                    },
                    {
                        "drugbank-id": "DB13140",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bezlotoxumab"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13535",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nebacumab"
                    },
                    {
                        "drugbank-id": "DB13886",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Human cytomegalovirus immune globulin"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Emicizumab"
                    },
                    {
                        "drugbank-id": "DB13976",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sulesomab"
                    },
                    {
                        "drugbank-id": "DB13979",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Besilesomab"
                    },
                    {
                        "drugbank-id": "DB14012",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Burosumab"
                    },
                    {
                        "drugbank-id": "DB14039",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Erenumab"
                    },
                    {
                        "drugbank-id": "DB14040",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Eptinezumab"
                    },
                    {
                        "drugbank-id": "DB14041",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fremanezumab"
                    },
                    {
                        "drugbank-id": "DB14042",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Galcanezumab"
                    },
                    {
                        "drugbank-id": "DB14211",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Fanolesomab"
                    },
                    {
                        "drugbank-id": "DB14580",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lecanemab"
                    },
                    {
                        "drugbank-id": "DB14597",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lanadelumab"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14776",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Camrelizumab"
                    },
                    {
                        "drugbank-id": "DB14778",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Setrusumab"
                    },
                    {
                        "drugbank-id": "DB14784",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gancotamab"
                    },
                    {
                        "drugbank-id": "DB14809",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Anetumab ravtansine"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB14824",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Icrucumab"
                    },
                    {
                        "drugbank-id": "DB14843",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Codrituzumab"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Brolucizumab"
                    },
                    {
                        "drugbank-id": "DB14871",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Xentuzumab"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14891",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vobarilizumab"
                    },
                    {
                        "drugbank-id": "DB14897",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Parsatuzumab"
                    },
                    {
                        "drugbank-id": "DB14905",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Emactuzumab"
                    },
                    {
                        "drugbank-id": "DB14907",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bevacizumab zirconium Zr 89"
                    },
                    {
                        "drugbank-id": "DB14908",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Refanezumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14952",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pamrevlumab"
                    },
                    {
                        "drugbank-id": "DB14959",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Opicinumab"
                    },
                    {
                        "drugbank-id": "DB14962",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Trastuzumab deruxtecan"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Margetuximab"
                    },
                    {
                        "drugbank-id": "DB14988",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Dalantercept"
                    },
                    {
                        "drugbank-id": "DB14997",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pateclizumab"
                    },
                    {
                        "drugbank-id": "DB15014",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gremubamab"
                    },
                    {
                        "drugbank-id": "DB15022",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Apomab"
                    },
                    {
                        "drugbank-id": "DB15044",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tafasitamab"
                    },
                    {
                        "drugbank-id": "DB15045",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ipafricept"
                    },
                    {
                        "drugbank-id": "DB15076",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Abrilumab"
                    },
                    {
                        "drugbank-id": "DB15089",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Frovocimab"
                    },
                    {
                        "drugbank-id": "DB15090",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tezepelumab"
                    },
                    {
                        "drugbank-id": "DB15101",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tigatuzumab"
                    },
                    {
                        "drugbank-id": "DB15104",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Telisotuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15113",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Utomilumab"
                    },
                    {
                        "drugbank-id": "DB15118",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Zolbetuximab"
                    },
                    {
                        "drugbank-id": "DB15135",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ponezumab"
                    },
                    {
                        "drugbank-id": "DB15160",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Asunercept"
                    },
                    {
                        "drugbank-id": "DB15172",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Suvratoxumab"
                    },
                    {
                        "drugbank-id": "DB15225",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mitazalimab"
                    },
                    {
                        "drugbank-id": "DB15252",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Nemolizumab"
                    },
                    {
                        "drugbank-id": "DB15277",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Gedivumab"
                    },
                    {
                        "drugbank-id": "DB15336",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Valanafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15349",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Sofituzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15354",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Evinacumab"
                    },
                    {
                        "drugbank-id": "DB15363",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Istiratumab"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15397",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with GMA 161"
                    },
                    {
                        "drugbank-id": "DB15409",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ladiratuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15415",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tomaralimab"
                    },
                    {
                        "drugbank-id": "DB15428",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vesencumab"
                    },
                    {
                        "drugbank-id": "DB15432",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pinatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15441",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lulizumab pegol"
                    },
                    {
                        "drugbank-id": "DB15443",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Lorukafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15453",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Naratuximab emtansine"
                    },
                    {
                        "drugbank-id": "DB14004",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Tildrakizumab"
                    },
                    {
                        "drugbank-id": "DB05679",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Ustekinumab"
                    },
                    {
                        "drugbank-id": "DB15559",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Zenocutuzumab"
                    },
                    {
                        "drugbank-id": "DB15898",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Atoltivimab"
                    },
                    {
                        "drugbank-id": "DB15899",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Maftivimab"
                    },
                    {
                        "drugbank-id": "DB15900",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Odesivimab"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Belantamab mafodotin"
                    },
                    {
                        "drugbank-id": "DB00039",
                        "description": "The therapeutic efficacy of Palifermin can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Pentamidine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "Leuprolide may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "Goserelin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Tositumomab may decrease the excretion rate of Folic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Tositumomab may decrease the excretion rate of Pyridoxine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Tositumomab may decrease the excretion rate of Fluvoxamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Tositumomab may decrease the excretion rate of Baclofen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Tositumomab may decrease the excretion rate of Amphetamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Tositumomab may decrease the excretion rate of Cevimeline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Tositumomab may decrease the excretion rate of Lorazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Tositumomab may decrease the excretion rate of Carbidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tositumomab may decrease the excretion rate of Tramadol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "Tositumomab may decrease the excretion rate of Fluconazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Tositumomab may decrease the excretion rate of Oseltamivir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Tositumomab may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Tositumomab may decrease the excretion rate of Reserpine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Tositumomab may decrease the excretion rate of Pantoprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Tositumomab may decrease the excretion rate of Gadodiamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Tositumomab may decrease the excretion rate of Pregabalin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Tositumomab may decrease the excretion rate of Temazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Tositumomab may decrease the excretion rate of Milrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Tositumomab may decrease the excretion rate of Butabarbital which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "Tositumomab may decrease the excretion rate of Ranolazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Tositumomab may decrease the excretion rate of Benzatropine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Tositumomab may decrease the excretion rate of Doxycycline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Tositumomab may decrease the excretion rate of Metoprolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Tositumomab may decrease the excretion rate of Isradipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Tositumomab may decrease the excretion rate of Diatrizoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Tositumomab may decrease the excretion rate of Topiramate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Tositumomab may decrease the excretion rate of Liothyronine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Tositumomab may decrease the excretion rate of Disopyramide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Tositumomab may decrease the excretion rate of Acarbose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Tositumomab may decrease the excretion rate of Venlafaxine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Tositumomab may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Tositumomab may decrease the excretion rate of Atomoxetine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Tositumomab may decrease the excretion rate of Etomidate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Tositumomab may decrease the excretion rate of Etonogestrel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Tositumomab may decrease the excretion rate of Ropivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Tositumomab may decrease the excretion rate of Ertapenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Tositumomab may decrease the excretion rate of Ibutilide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Tositumomab may decrease the excretion rate of Pentobarbital which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Tositumomab may decrease the excretion rate of Acetaminophen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Tositumomab may decrease the excretion rate of Piperacillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tositumomab may decrease the excretion rate of Tolcapone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Tositumomab may decrease the excretion rate of Nitroprusside which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Tositumomab may decrease the excretion rate of Hydromorphone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Tositumomab may decrease the excretion rate of Ethambutol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Tositumomab may decrease the excretion rate of Metformin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "Tositumomab may decrease the excretion rate of Methadone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Tositumomab may decrease the excretion rate of Pyrazinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Tositumomab may decrease the excretion rate of Cetirizine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Tositumomab may decrease the excretion rate of Clobazam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Tositumomab may decrease the excretion rate of Megestrol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Tositumomab may decrease the excretion rate of Aztreonam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Tositumomab may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Tositumomab may decrease the excretion rate of Sulfadiazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Tositumomab may decrease the excretion rate of Sucralfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Tositumomab may decrease the excretion rate of Thiethylperazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Tositumomab may decrease the excretion rate of Timolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Tositumomab may decrease the excretion rate of Palonosetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Tositumomab may decrease the excretion rate of Nisoldipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Tositumomab may decrease the excretion rate of Eszopiclone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Tositumomab may decrease the excretion rate of Alprazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Tositumomab may decrease the excretion rate of Rosiglitazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Tositumomab may decrease the excretion rate of Pramipexole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Tositumomab may decrease the excretion rate of Ampicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Tositumomab may decrease the excretion rate of Secobarbital which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Tositumomab may decrease the excretion rate of Methylphenidate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Tositumomab may decrease the excretion rate of Nitric Oxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Tositumomab may decrease the excretion rate of Trimethoprim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Tositumomab may decrease the excretion rate of Duloxetine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Tositumomab may decrease the excretion rate of Chlorpromazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Tositumomab may decrease the excretion rate of Buspirone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Tositumomab may decrease the excretion rate of Fosinopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Tositumomab may decrease the excretion rate of Flutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Tositumomab may decrease the excretion rate of Haloperidol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Tositumomab may decrease the excretion rate of Cefdinir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Tositumomab may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Tositumomab may decrease the excretion rate of Azelaic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Tositumomab may decrease the excretion rate of Methoxsalen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Tositumomab may decrease the excretion rate of Lamotrigine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Tositumomab may decrease the excretion rate of Zanamivir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Tositumomab may decrease the excretion rate of Propranolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Tositumomab may decrease the excretion rate of Levocarnitine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Tositumomab may decrease the excretion rate of Gadoteridol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Tositumomab may decrease the excretion rate of Labetalol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Tositumomab may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Tositumomab may decrease the excretion rate of Chloroquine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Tositumomab may decrease the excretion rate of Bisoprolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Tositumomab may decrease the excretion rate of Testosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Tositumomab may decrease the excretion rate of Clorazepic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Tositumomab may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Tositumomab may decrease the excretion rate of Dyphylline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Tositumomab may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Tositumomab may decrease the excretion rate of Metaxalone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Tositumomab may decrease the excretion rate of Verapamil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Tositumomab may decrease the excretion rate of Nilutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Tositumomab may decrease the excretion rate of Sumatriptan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Tositumomab may decrease the excretion rate of Chlorpropamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Tositumomab may decrease the excretion rate of Midazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Tositumomab may decrease the excretion rate of Flurazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Tositumomab may decrease the excretion rate of Phentolamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Tositumomab may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tositumomab may decrease the excretion rate of Tamsulosin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Tositumomab may decrease the excretion rate of Lamivudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Tositumomab may decrease the excretion rate of Oxacillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Tositumomab may decrease the excretion rate of Nedocromil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Tositumomab may decrease the excretion rate of Lisinopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Tositumomab may decrease the excretion rate of Thiabendazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Tositumomab may decrease the excretion rate of Nateglinide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Tositumomab may decrease the excretion rate of Pralidoxime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Tositumomab may decrease the excretion rate of Gadobenic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tositumomab may decrease the excretion rate of Tetracycline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Tositumomab may decrease the excretion rate of Meropenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Tositumomab may decrease the excretion rate of Potassium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Tositumomab may decrease the excretion rate of Phenelzine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Tositumomab may decrease the excretion rate of Propantheline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Tositumomab may decrease the excretion rate of Estradiol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Tositumomab may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Tositumomab may decrease the excretion rate of Perindopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Tositumomab may decrease the excretion rate of Fenoldopam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Tositumomab may decrease the excretion rate of Dicyclomine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Tositumomab may decrease the excretion rate of Ribavirin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tositumomab may decrease the excretion rate of Tadalafil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Tositumomab may decrease the excretion rate of Fosfomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Tositumomab may decrease the excretion rate of Diazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tositumomab may decrease the excretion rate of Tolazamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Tositumomab may decrease the excretion rate of Dobutamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Tositumomab may decrease the excretion rate of Oxazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Tositumomab may decrease the excretion rate of Ranitidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Tositumomab may decrease the excretion rate of Terbutaline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Tositumomab may decrease the excretion rate of Testolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Tositumomab may decrease the excretion rate of Triazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Tositumomab may decrease the excretion rate of Didanosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tositumomab may decrease the excretion rate of Tinidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Tositumomab may decrease the excretion rate of Amantadine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Tositumomab may decrease the excretion rate of Almotriptan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Tositumomab may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Tositumomab may decrease the excretion rate of Isoniazid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Tositumomab may decrease the excretion rate of Rizatriptan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Tositumomab may decrease the excretion rate of Pindolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Tositumomab may decrease the excretion rate of Mepivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Tositumomab may decrease the excretion rate of Zaleplon which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Tositumomab may decrease the excretion rate of Methyldopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Tositumomab may decrease the excretion rate of Ramelteon which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Tositumomab may decrease the excretion rate of Dopamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Tositumomab may decrease the excretion rate of Auranofin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Tositumomab may decrease the excretion rate of Salbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Tositumomab may decrease the excretion rate of Levobupivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Tositumomab may decrease the excretion rate of Ganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Tositumomab may decrease the excretion rate of Edrophonium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Tositumomab may decrease the excretion rate of Metyrapone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Tositumomab may decrease the excretion rate of Guanfacine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Tositumomab may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Tositumomab may decrease the excretion rate of Phylloquinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Tositumomab may decrease the excretion rate of Probenecid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Tositumomab may decrease the excretion rate of Tolterodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Tositumomab may decrease the excretion rate of Fenofibrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Tositumomab may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Tositumomab may decrease the excretion rate of Lubiprostone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Tositumomab may decrease the excretion rate of Abacavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Tositumomab may decrease the excretion rate of Amoxicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Tositumomab may decrease the excretion rate of Glipizide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Tositumomab may decrease the excretion rate of Clonazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Tositumomab may decrease the excretion rate of Promethazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Tositumomab may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Tositumomab may decrease the excretion rate of Sibutramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Tositumomab may decrease the excretion rate of Nifedipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tositumomab may decrease the excretion rate of Tolbutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Tositumomab may decrease the excretion rate of Rabeprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tositumomab may decrease the excretion rate of Tiludronic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Tositumomab may decrease the excretion rate of Doxacurium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Tositumomab may decrease the excretion rate of Levofloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Tositumomab may decrease the excretion rate of Flavoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Tositumomab may decrease the excretion rate of Nefazodone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Tositumomab may decrease the excretion rate of Bupropion which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Tositumomab may decrease the excretion rate of Trimetrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Tositumomab may decrease the excretion rate of Guanethidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Tositumomab may decrease the excretion rate of Naloxone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Tositumomab may decrease the excretion rate of Nadolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Tositumomab may decrease the excretion rate of Flumazenil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Tositumomab may decrease the excretion rate of Fomepizole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Tositumomab may decrease the excretion rate of Estazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Tositumomab may decrease the excretion rate of Ketamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Tositumomab may decrease the excretion rate of Quetiapine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Tositumomab may decrease the excretion rate of Metoclopramide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Tositumomab may decrease the excretion rate of Gemfibrozil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Tositumomab may decrease the excretion rate of Iodixanol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Tositumomab may decrease the excretion rate of Sitagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Tositumomab may decrease the excretion rate of Paliperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Tositumomab may decrease the excretion rate of Varenicline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Tositumomab may decrease the excretion rate of Arformoterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Tositumomab may decrease the excretion rate of Hydralazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Tositumomab may decrease the excretion rate of Penbutolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Tositumomab may decrease the excretion rate of Rasagiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tositumomab may decrease the excretion rate of Tiotropium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Tositumomab may decrease the excretion rate of Testosterone propionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Tositumomab may decrease the excretion rate of Amrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Tositumomab may decrease the excretion rate of Oxybenzone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Tositumomab may decrease the excretion rate of Allylestrenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Tositumomab may decrease the excretion rate of Fenproporex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Tositumomab may decrease the excretion rate of Bromazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Tositumomab may decrease the excretion rate of Chloral hydrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Tositumomab may decrease the excretion rate of Metamfetamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Tositumomab may decrease the excretion rate of Ketazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Tositumomab may decrease the excretion rate of Valganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Tositumomab may decrease the excretion rate of Sorbitol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Tositumomab may decrease the excretion rate of Topiroxostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Tositumomab may decrease the excretion rate of Estrone sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Tositumomab may decrease the excretion rate of Lorcaserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Tositumomab may decrease the excretion rate of Pegaptanib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Tositumomab may decrease the excretion rate of Milnacipran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Tositumomab may decrease the excretion rate of Clevidipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Tositumomab may decrease the excretion rate of Lofexidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Tositumomab may decrease the excretion rate of Ezogabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Tositumomab may decrease the excretion rate of Migalastat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Tositumomab may decrease the excretion rate of Brivaracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Tositumomab may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Tositumomab may decrease the excretion rate of Ipilimumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Tositumomab may decrease the excretion rate of Icatibant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Tositumomab may decrease the excretion rate of Alogliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Tositumomab may decrease the excretion rate of Doripenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Tositumomab may decrease the excretion rate of Nalmefene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Tositumomab may decrease the excretion rate of Droxidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Tositumomab may decrease the excretion rate of Levocetirizine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Tositumomab may decrease the excretion rate of Saxagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Tositumomab may decrease the excretion rate of Telavancin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Tositumomab may decrease the excretion rate of Prucalopride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Tositumomab may decrease the excretion rate of Flupirtine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Tositumomab may decrease the excretion rate of Dalfampridine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Tositumomab may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Tositumomab may decrease the excretion rate of Fesoterodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Tositumomab may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Tositumomab may decrease the excretion rate of Methyltestosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Tositumomab may decrease the excretion rate of Ammonium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Tositumomab may decrease the excretion rate of Dimercaprol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Tositumomab may decrease the excretion rate of Mangafodipir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Tositumomab may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Tositumomab may decrease the excretion rate of Plerixafor which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tositumomab may decrease the excretion rate of Tiopronin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Tositumomab may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Tositumomab may decrease the excretion rate of Ioflupane I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Tositumomab may decrease the excretion rate of Deferiprone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "Tositumomab may decrease the excretion rate of N methylnicotinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Tositumomab may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Tositumomab may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Tositumomab may decrease the excretion rate of Aclidinium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Tositumomab may decrease the excretion rate of Enzalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Tositumomab may decrease the excretion rate of Teduglutide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Tositumomab may decrease the excretion rate of Formestane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Tositumomab may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Tositumomab may decrease the excretion rate of Trametinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Tositumomab may decrease the excretion rate of Levomilnacipran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Tositumomab may decrease the excretion rate of Macitentan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Tositumomab may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Tositumomab may decrease the excretion rate of Ledipasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Tositumomab may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Tositumomab may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Tositumomab may decrease the excretion rate of Vortioxetine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tositumomab may decrease the excretion rate of Tasimelteon which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Tositumomab may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Tositumomab may decrease the excretion rate of Trimebutine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Tositumomab may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Tositumomab may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Tositumomab may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Tositumomab may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Tositumomab may decrease the excretion rate of Stiripentol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Tositumomab may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Tositumomab may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Tositumomab may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Tositumomab may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Tositumomab may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Tositumomab may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Tositumomab may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Tositumomab may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Tositumomab may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Tositumomab may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Tositumomab may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Tositumomab may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Tositumomab may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Tositumomab may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Tositumomab may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Tositumomab may decrease the excretion rate of Viloxazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Tositumomab may decrease the excretion rate of Etoperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Tositumomab may decrease the excretion rate of Lorpiprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Tositumomab may decrease the excretion rate of Arotinolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Tositumomab may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Tositumomab may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Tositumomab may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Tositumomab may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Tositumomab may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Tositumomab may decrease the excretion rate of Blonanserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Tositumomab may decrease the excretion rate of Melperone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Tositumomab may decrease the excretion rate of Methylene blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Tositumomab may decrease the excretion rate of Pirlindole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Tositumomab may decrease the excretion rate of Toloxatone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Tositumomab may decrease the excretion rate of Tegafur which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Tositumomab may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Tositumomab may decrease the excretion rate of Imidafenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Tositumomab may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Tositumomab may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Tositumomab may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Tositumomab may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Tositumomab may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Tositumomab may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Tositumomab may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Tositumomab may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Tositumomab may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Tositumomab may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Tositumomab may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Tositumomab may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Tositumomab may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Tositumomab may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Tositumomab may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Tositumomab may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Tositumomab may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Tositumomab may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Tositumomab may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Tositumomab may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Tositumomab may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Tositumomab may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Tositumomab may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Tositumomab may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Tositumomab may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Tositumomab may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Tositumomab may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Tositumomab may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Tositumomab may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Tositumomab may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Tositumomab may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Tositumomab may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Tositumomab may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Tositumomab may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Tositumomab may decrease the excretion rate of Opium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Tositumomab may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Tositumomab may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Tositumomab may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Tositumomab may decrease the excretion rate of Pyrantel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Tositumomab may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Tositumomab may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Tositumomab may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Tositumomab may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Tositumomab may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Tositumomab may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Tositumomab may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Tositumomab may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Tositumomab may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Tositumomab may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Tositumomab may decrease the excretion rate of Pitolisant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Tositumomab may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Tositumomab may decrease the excretion rate of Tropisetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Tositumomab may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Tositumomab may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Tositumomab may decrease the excretion rate of Delafloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Tositumomab may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Tositumomab may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Tositumomab may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Tositumomab may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Tositumomab may decrease the excretion rate of Propiverine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Tositumomab may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Tositumomab may decrease the excretion rate of Tiapride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Tositumomab may decrease the excretion rate of Levosalbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Tositumomab may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Tositumomab may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Tositumomab may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Tositumomab may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Tositumomab may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Tositumomab may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Tositumomab may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Tositumomab may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Tositumomab may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Tositumomab may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Tositumomab may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Tositumomab may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Tositumomab may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Tositumomab may decrease the excretion rate of Estradiol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Tositumomab may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Tositumomab may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Tositumomab may decrease the excretion rate of Estradiol valerate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Tositumomab may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Tositumomab may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Tositumomab may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Tositumomab may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Tositumomab may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Tositumomab may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Tositumomab may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Tositumomab may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Tositumomab may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Tositumomab may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Tositumomab may decrease the excretion rate of Solriamfetol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Tositumomab may decrease the excretion rate of Pyrithione which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Tositumomab may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Tositumomab may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Tositumomab may decrease the excretion rate of Cimetidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Tositumomab may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Tositumomab may decrease the excretion rate of Amitriptyline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Tositumomab may decrease the excretion rate of Imipramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Tositumomab may decrease the excretion rate of Doxepin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Tositumomab may decrease the excretion rate of Codeine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Tositumomab may decrease the excretion rate of Meperidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Tositumomab may decrease the excretion rate of Fentanyl which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Tositumomab may decrease the excretion rate of Emtricitabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Tositumomab may decrease the excretion rate of Desipramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Tositumomab may decrease the excretion rate of Clomipramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Tositumomab may decrease the excretion rate of Dimetacrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Tositumomab may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Tositumomab may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Tositumomab may decrease the excretion rate of Bepotastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Tositumomab may decrease the excretion rate of Isotretinoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Tositumomab may decrease the excretion rate of Permethrin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Tositumomab may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Tositumomab may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Tositumomab may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Tositumomab may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Tositumomab may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Tositumomab may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Tositumomab may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Tositumomab may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Tositumomab may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Tositumomab may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Tositumomab may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Tositumomab may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Tositumomab may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Tositumomab may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Tositumomab may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Efonidipine may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Cicletanine may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Tositumomab may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of myelosuppression can be increased when Tositumomab is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Tositumomab may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The risk or severity of adverse effects can be increased when Allopurinol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Tositumomab can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Tositumomab is combined with Inebilizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}